Management Program Seminoma
55-60 % of patients with testicular cancer are diagnosed with seminoma, of these 85 % will only have disease in the testicle (CS1) while 15 % will have metastatic disease to lymph nodes, the lungs or other organs. Even with metastatic disease most patients are cured.
Earlier, patients with seminoma often received adjuvant radiotherapy, or radiotherapy as treatment for metastatic disease. As radiotherapy may increase the risk of secondary cancer, radiotherapy is today less frequently used. Patients without metastasis are often managed by surveillance, or receive adjuvant carboplatin.
Most patients with metastatic disease are treated with chemotherapy. Surgery is rarely used after chemotherapy.